News
European Commission approves Eylea 8 mg with extended 6-month treatment interval for nAMD and visual impairment due to DME: Berlin Saturday, June 28, 2025, 09:00 Hrs [IST] The Eur ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback